Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Medical Principles and Practice. 2005; 14 (2): 102-106
em Inglês | IMEMR | ID: emr-73510

RESUMO

To study the prevalence and genotype distribution of hepatitis G virus [HGV] in hemodialysis patients in East Anatolia, Turkey. Subjects and Materials: Eighty-nine hemodialysis patients and 30 healthy individuals were analyzed by using reverse-transcriptase nested polymerase chain reaction with primers specific for 5' untranslated region. HGV genotyping was performed by PCR and three randomly selected HGV-positive samples were sequenced. Of the 89 hemodialysis patients, HGV RNA was detected in 9 [10.2%]. All of our isolates were assigned to genotype 2. Our results showed that hemodialysis patients carry the risk for HGV infection in East Anatolia, Turkey


Assuntos
Humanos , Masculino , Feminino , Genótipo , Prevalência , Diálise Renal , Estudos Soroepidemiológicos
2.
Medical Principles and Practice. 2005; 14 (4): 268-271
em Inglês | IMEMR | ID: emr-73545

RESUMO

To investigate etiological role of Epstein-Barr virus [EBV] DNA in breast cancer. Materials and The presence of EBV DNA in 57 breast cancertissues was investigated with a sensitive PCR assay. The breast cancer tissues were from invasive ductular [n = 28], lobular [n = 20] and other miscellaneous carcinomas [n = 9]. Tissues from normal breasts and patients with various benign breast diseases [n = 55]: fibrocystic disease [n = 34], fibroadenoma [n= 16], hyperplasia, and granulomatous mastitis [n = 5], were used as control samples, flesults: EBV DNA was detected in 13 [23%] cancerous tissues [7 ductular, 4 lobular, 2 other carcinoma] and 19 [35%] in the control tissues. The difference between EBV presence in malignant and benign tissues was not statistically significant [p>0.05]. The presence of EBV DNA was detected almost equally in both breast cancer and normal tissues, which indicates no etiological role for EBV in breast cancer. We suggest further etiological studies


Assuntos
Humanos , Feminino , Antígenos Nucleares do Vírus Epstein-Barr , Viroses/complicações , Infecções por Vírus Epstein-Barr , Reação em Cadeia da Polimerase , Fatores de Risco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA